| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Department of Public Health, University of Massachusetts, Amherst, Massachusetts; 2 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 3 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; 4 Department of Medicine, Boston University Medical School; Departments of 5 Epidemiology and 6 Nutrition, Harvard School of Public Health, Boston, Massachusetts; and 7 Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina
Requests for reprints: Elizabeth R. Bertone-Johnson, Department of Public Health, University of Massachusetts, 715 North Pleasant Street, Amherst, MA 01003-9304. Phone: 413-577-1672; Fax: 413-545-1645. E-mail: ebertone{at}schoolph.umass.edu
Several lines of evidence suggest that vitamin D may reduce incidence of breast cancer, but few epidemiologic studies have addressed the relation of plasma vitamin D metabolites to the risk of this disease. We prospectively examined the relationship between plasma levels of 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25(OH)2D] and risk of breast cancer in a case-control study nested within the Nurses' Health Study cohort. Blood samples were collected from study participants in 1989-1990. Breast cancer cases developing between blood collection and June 1, 1996, were matched to cancer-free controls on the basis of age, menopausal status, and other factors. Stored plasma samples from 701 cases and 724 controls were available for metabolite analysis. Cases had a lower mean 25(OH)D level than controls (P = 0.01), but mean 1,25(OH)2D levels were similar (P = 0.49). High levels of both metabolites were associated with a nonsignificant lower risk of breast cancer. Women in the highest quintile of 25(OH)D had a relative risk of 0.73 (95% confidence interval = 0.49-1.07; Ptrend = 0.06) compared with those in the lowest quintile. For 1,25(OH)2D, the comparable relative risk was 0.76 (95% confidence interval = 0.52-1.11; Ptrend = 0.39). For both metabolites, the association was stronger in women ages 60 years and older, but results were not statistically significant. Our findings suggest that high levels of 25(OH)D, and perhaps 1,25(OH)2D, may be modestly associated with reduced risk of breast cancer.
This article has been cited by other articles:
|
|
 |
|
  R. T. Chlebowski, K. C. Johnson, C. Kooperberg, M. Pettinger, J. Wactawski-Wende, T. Rohan, J. Rossouw, D. Lane, M. J. O'Sullivan, S. Yasmeen, et al. Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer J Natl Cancer Inst, November 19, 2008; 100(22): 1581 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Mahoney, T. Bevers, E. Linos, and W. C. Willett Opportunities and Strategies for Breast Cancer Prevention Through Risk Reduction CA Cancer J Clin, November 3, 2008; (2008) CA.2008.0016v1. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Kilkkinen, P. Knekt, M. Heliovaara, H. Rissanen, J. Marniemi, T. Hakulinen, and A. Aromaa Vitamin D Status and the Risk of Lung Cancer: A Cohort Study in Finland Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3274 - 3278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rossi, J. K. McLaughlin, P. Lagiou, C. Bosetti, R. Talamini, L. Lipworth, A. Giacosa, M. Montella, S. Franceschi, E. Negri, et al. Vitamin D intake and breast cancer risk: a case-control study in Italy Ann. Onc., August 18, 2008; (2008) mdn550v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Colditz and D. M. Winn Criteria for the Evaluation of Large Cohort Studies: An Application to the Nurses' Health Study J Natl Cancer Inst, July 2, 2008; 100(13): 918 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L Neuhouser, B. Sorensen, B. W Hollis, A. Ambs, C. M Ulrich, A. McTiernan, L. Bernstein, S. Wayne, F. Gilliland, K. Baumgartner, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors Am. J. Clinical Nutrition, July 1, 2008; 88(1): 133 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wang-Gillam, D. A. Miles, and L. F. Hutchins Evaluation of Vitamin D Deficiency in Breast Cancer Patients on Bisphosphonates Oncologist, July 1, 2008; 13(7): 821 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Michal Freedman, A. C. Looker, S.-C. Chang, and B. I. Graubard Response: Re: Prospective Study of Vitamin D and Cancer Mortality in the United States J Natl Cancer Inst, June 4, 2008; 100(11): 827 - 828. [Full Text] [PDF]
|
|
|
|
|
|
C. F. Garland, E. D. Gorham, C. A. Baggerly, and F. C. Garland Re: Prospective Study of Vitamin D and Cancer Mortality in the United States J Natl Cancer Inst, June 4, 2008; 100(11): 826 - 827. [Full Text] [PDF]
|
|
|
|
|
|
S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E. J. Mutschelknauss, D. Flesch-Janys, and J. Chang-Claude The Gc2 Allele of the Vitamin D Binding Protein Is Associated with a Decreased Postmenopausal Breast Cancer Risk, Independent of the Vitamin D Status Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1339 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Freedman, S.-C. Chang, R. T. Falk, M. P. Purdue, W.-Y. Huang, C. A. McCarty, B. W. Hollis, B. I. Graubard, C. D. Berg, and R. G. Ziegler Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 889 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E. J. Mutschelknauss, D. Flesch-Janys, and J. Chang-Claude Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study Carcinogenesis, January 1, 2008; 29(1): 93 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. John, G. G. Schwartz, J. Koo, W. Wang, and S. A. Ingles Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Breast Cancer Risk in a Multiethnic Population Am. J. Epidemiol., December 15, 2007; 166(12): 1409 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Freedman, A. C. Looker, S.-C. Chang, and B. I. Graubard Prospective Study of Serum Vitamin D and Cancer Mortality in the United States J Natl Cancer Inst, November 7, 2007; 99(21): 1594 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Mullin and A. Dobs Vitamin D and Its Role in Cancer and Immunity: A Prescription for Sunlight Nutr Clin Pract, June 1, 2007; 22(3): 305 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lin, J. E. Manson, I-M. Lee, N. R. Cook, J. E. Buring, and S. M. Zhang Intakes of Calcium and Vitamin D and Breast Cancer Risk in Women Arch Intern Med, May 28, 2007; 167(10): 1050 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Forman, E. Giovannucci, M. D. Holmes, H. A. Bischoff-Ferrari, S. S. Tworoger, W. C. Willett, and G. C. Curhan Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension Hypertension, May 1, 2007; 49(5): 1063 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Tworoger, I-M. Lee, J. E. Buring, B. Rosner, B. W. Hollis, and S. E. Hankinson Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 783 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Knight, M. Lesosky, H. Barnett, J. M. Raboud, and R. Vieth Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 422 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Knight, C. M. Vachon, R. A. Vierkant, R. Vieth, J. R. Cerhan, and T. A. Sellers No association between 25-hydroxyvitamin d and mammographic density. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1988 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Cui and T. E. Rohan Vitamin d, calcium, and breast cancer risk: a review. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1427 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Y. Chen, E. R. Bertone-Johnson, D. J. Hunter, W. C. Willett, and S. E. Hankinson Associations Between Polymorphisms in the Vitamin D Receptor and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2335 - 2339. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
